Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health Service (NHS) Care of Multiple Sclerosis

Launched by QUEEN MARY UNIVERSITY OF LONDON · Aug 1, 2025

Keywords

ClinConnect Summary

This study is looking at how a special computer program using artificial intelligence (AI) can help doctors better understand MRI brain scans for people with Multiple Sclerosis (MS). MS is a long-term condition that affects the brain and spinal cord, and it’s important to start treatment early and regularly check if the treatment is working. Right now, doctors look at MRI scans with their eyes, but this can sometimes miss important changes because it’s hard to spot new problems or lesions. The AI program, called “icobrain ms,” helps by highlighting areas of concern and providing detailed reports, which may help doctors make better decisions about your MS treatment.

If you have been diagnosed with MS or have symptoms that suggest MS, are currently having MRI scans, and are on MS treatment, you might be able to join this study. Participants will have their MRI scans reviewed using this AI tool alongside the usual doctor’s review. You will also need access to a smartphone, tablet, or computer during the study. This research aims to show that using AI can improve the way MS is monitored, potentially leading to quicker and more accurate treatment decisions. If you’re interested and meet these criteria, this trial could offer a new way to help manage your MS care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinically Isolated Syndrome suggestive of demyelination (CIS) or definitive diagnosis of MS.
• • Undergoing MRI head investigation.
• • On an MS DMT pathway.
• • Access to a smartphone, tablet or computer.
• Exclusion Criteria:
• • patients with Multiples Sclerosis participating in a randomised controlled CTIMP (participating in a single arm study may be included, provided this is in line with the other protocol).